This inventor holds 4 USPTO granted patents and 11 published patent applications and 1 EPO patent. Top assignees: Invitae Corporation, Laboratory Corporation of America Holdings, Leland Stanford Junior University. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2021-2024
Title: The Innovations of Carlos L Araya
Introduction
Carlos L Araya is a notable inventor based in Palo Alto, CA (US). He has made significant contributions to the field of genetic and genomic testing through his innovative patents. With a total of 4 patents, Araya's work focuses on optimizing the interpretation of molecular variants.
Latest Patents
One of his latest patents is a molecular evidence platform designed for auditable, continuous optimization of variant interpretation in genetic and genomic testing and analysis. This patent discloses system, method, and computer program product embodiments aimed at optimizing the determination of a phenotypic impact of a molecular variant identified in molecular tests, samples, or reports of subjects. The platform regularly incorporates, updates, monitors, validates, selects, and audits the best-performing evidence models for the interpretation of molecular variants across a plurality of evidence classes.
Career Highlights
Throughout his career, Carlos L Araya has worked with prominent companies such as Invitae Corporation and Laboratory Corporation of America Holdings. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of molecular testing.
Collaborations
Some of his notable coworkers include Alexandre Colavin and Jason A Reuter. Their collaboration has contributed to the advancement of technologies in genetic and genomic testing.
Conclusion
Carlos L Araya's contributions to the field of genetic and genomic testing through his patents demonstrate his commitment to innovation. His work continues to influence the optimization of molecular variant interpretation, paving the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile